Ratings Johnson Health Tech .Co., Ltd.

Equities

1736

TW0001736007

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
89.9 ^TWD	+2.04%		+2.74%	+30.86%

May. 10	Johnson Health Tech .Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 10	Leisure Fitness Equipment, LLC announced that it expects to receive TWD 1.08942 billion in funding from Johnson Health Tech .Co., Ltd.	CI

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

The company's profit outlook over the next few years is a strong asset.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company sustains low margins.
For the past year, analysts have significantly revised downwards their profit estimates.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Recreational Products

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
JOHNSON HEALTH TECH .CO., LTD.	+30.86%	823M		-
AMER SPORTS OYJ	+4.27%	5.09B	-	-
FLUIDRA, S.A.	+24.67%	4.64B		B+
ACUSHNET HOLDINGS CORP.	+2.45%	3.99B		B-
TOPGOLF CALLAWAY BRANDS CORP.	+8.16%	2.81B		B+
TECHNOGYM S.P.A.	+4.36%	2.04B		B+
PELOTON INTERACTIVE, INC.	-30.54%	1.55B		D
MIPS AB	+11.71%	974M		B
FENIX OUTDOOR INTERNATIONAL AG	-10.21%	854M	-	B-
YONEX CO., LTD.	+15.77%	842M		-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes